Antimicrobial Agents and Chemotherapy Vol 56 No 5 May 2012

AntimicrobialAction and Cell Agglutination by the Eosinophil Cationic Protein Are Modulatedby the Cell Wall Lipopolysaccharide Structure

David Pulido, Mohammed Moussaoui, David Andreu, M. Victòria Nogués, Marc Torrent, and Ester Boix

Target-and Resistance-Based Mechanistic Studies with TP-434, a Novel FluorocyclineAntibiotic

Trudy H. Grossman, Agata L. Starosta, Corey Fyfe, William O'Brien, David M. Rothstein, Aleksandra Mikolajka, Daniel N. Wilson, and Joyce A. Sutcliffe

Anti-HumanImmunodeficiency Virus Type 1 Activity of Novel 6-Substituted1-Benzyl-3-(3,5-Dimethylbenzyl)Uracil Derivatives

Paula Ordonez, Takayuki Hamasaki, Yohei Isono, Norikazu Sakakibara, Masahiro Ikejiri, Tokumi Maruyama, and Masanori Baba

MK-4815,a Potential New Oral Agent for Treatment of Malaria

Mary Ann Powles, John Allocco, Lai Yeung, Bakela Nare, Paul Liberator, and Dennis Schmatz

TargetedIntracellular Delivery of Antituberculosis Drugs to Mycobacteriumtuberculosis-Infected Macrophages via Functionalized Mesoporous SilicaNanoparticles

Daniel L. Clemens, Bai-Yu Lee, Min Xue, Courtney R. Thomas, Huan Meng, Daniel Ferris, Andre E. Nel, Jeffrey I. Zink, and Marcus A. Horwitz

Inhibitionof Bacterial Biofilm Formation and Swarming Motility by a Small SyntheticCationic Peptide

César de la Fuente-Núñez, Victoria Korolik, Manjeet Bains, Uyen Nguyen, Elena B. M. Breidenstein, Shawn Horsman, Shawn Lewenza, Lori Burrows, and Robert E. W. Hancock